Skip to main content
TipRanks
Go Ultimate75% OFF

Fredric Eshelman Insider Profile

11 Followers

Fredric Eshelman, Director at Hyperion DeFi, holds 25.52M shares in Aravive (Ticker: ARAV), holds 1.30M shares in Hyperion DeFi (Ticker: HYPD), holds 2.08M shares in Medicines Co (Ticker: MDCO).

Fredric Eshelman's Trading History

ARAV
Aravive
Oct 26, 2022―Uninformative Buy14.84M$1.02M
HYPD
Hyperion DeFi
Nov 22, 2021DirectorUninformative Buy―$3.35M
MDCO
Medicines Co
Jun 04, 2018―Uninformative Buy―$176.31M
GTHX
G1 Therapeutics
Nov 15, 2017―Informative Buy4.93M$26.38M
BHC
Bausch Health Companies
May 05, 2017DirectorUninformative Buy―$0.00
FURX
Furiex Pharmaceuticals
――――

You May Also Like

Fredric Eshelman insider profile FAQ

What is the percentage of profitable transactions made by Fredric Eshelman?
The percentage of profitable transactions made by Fredric Eshelman is 40%.
What is the average return per transaction made by Fredric Eshelman?
The average return per transaction made by Fredric Eshelman is 14.60%.
What stocks does Fredric Eshelman hold?
Fredric Eshelman holds: HYPD, MDCO, BHC, ARAV, GTHX, FURX stocks.
What was Fredric Eshelman’s latest transaction?
Fredric Eshelman’s latest transaction was an Uninformative Buy of $14.84M.
What was Fredric Eshelman's most profitable transaction?
Fredric Eshelman’s most profitable transaction was an Informative Buy of GTHX stock on November 15, 2017. The return on the trade was 118.30%.
What is Fredric Eshelman's role in Hyperion DeFi?
Fredric Eshelman's role in Hyperion DeFi is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.